Abstract

ABSTRACTA series of N,N-disubstituted piperazines were synthesized containing the structural elements of both methylenedioxybenzylpiperazine (MDBP) and trifluoromethylphenylpiperazine (TFMPP) in a single molecule. These six potential designer drug molecules having a regioisomeric relationship were compared in gas chromatography-mass spectrometry (GC–MS), gas chromatography-infrared spectroscopy and serotonin receptor affinity studies. These compounds were separated by capillary gas chromatography on an Rxi®-17Sil MS stationary phase film and the elution order appears to be determined by the position of aromatic ring substitution.The majority of electron ionization mass spectral fragment ions occur via processes initiated by one of the two nitrogen atoms of the piperazine ring. The major electron ionization mass spectrometry (EI-MS) fragment ions observed in all six of these regioisomeric substances occur at m/z = 364, 229, 163 and 135. The relative intensity of the various fragment ions is also equivalent in each of the six EI-MS spectra. The vapour phase infrared spectra provide a number of absorption bands to differentiate among the six individual compounds on this regioisomeric set. Thus, the mass spectra place these compounds into a single group and the vapour phase infrared spectra differentiate among the six regioisomeric possibilities.All of the TFMPP–MDBP regioisomers displayed significant binding to 5-HT2B receptors and in contrast to 3-TFMPP, most of these TFMPP–MDBP isomers did not show significant binding at 5-HT1 receptor subtypes. Only the 3-TFMPP-3,4-MDBP (Compound 5) isomer displayed affinity comparable to 3-TFMPP at 5-HT1A receptors (Ki = 188 nmol/L).

Highlights

  • The compounds in this paper are hybrid analogues containing the structural fragments of both 1-(3-trifluoromethylphenyl) piperazine (3-TFMPP) and 1-(3,4methylenedioxybenzyl) piperazine (3,4-MDBP) drugs of abuse in a single molecule

  • A series of six potential designer N,N-disubstituted piperazines were compared in gas chromatography-mass spectrometry (GC–MS) and Gas chromatography–IR spectroscopy (GC–IR) studies

  • These compounds contain the structural fragments of 1-(3-TFMPP) and 1-(3,4-MDBP) drugs of abuse in a single molecule

Read more

Summary

Introduction

The compounds in this paper are hybrid analogues containing the structural fragments of both 1-(3-trifluoromethylphenyl) piperazine (3-TFMPP) and 1-(3,4methylenedioxybenzyl) piperazine (3,4-MDBP) drugs of abuse in a single molecule. Legal control has stimulated the development of numerous designer drug analogues and these molecular modifications are often an attempt to obtain novel psychoactive substances not controlled by existing regulations This phenomenon has been observed in synthetic cannabinoids [4,5], phenethylamine-type drugs of abuse including amphetamine [6], MDMA [7,8], cathinone derivatives or bath salts [9,10] and other clandestine drug series [11,12]. These designer-style structural alterations have been encountered in the piperazine compounds, and the modification of the controlled substance N-BZP has led to 1-(3,4-MDBP), the methylenedioxy analogue of BZP

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call